John Wates
Family · Edgefield, SCNPI 1639284938
Payments from drug & device makers
Across 182 payments — averaging $17.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$573
- Lilly USA, LLC$446
- Novo Nordisk$331
- AstraZeneca$229
- Takeda Pharmaceuticals U.S.A., Inc.$201
- Novartis$192
- plus $1K from 17 others
What the payments were for
- Food & beverage$3,148100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 30 | $573 |
| Lilly USA, LLC | 21 | $446 |
| Novo Nordisk | 25 | $331 |
| AstraZeneca | 15 | $229 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $201 |
| Novartis | 10 | $192 |
| Abbott | 11 | $182 |
| Dexcom, Inc. | 7 | $113 |
| Pfizer | 6 | $111 |
| Amgen | 7 | $111 |
| Boehringer Ingelheim | 6 | $97 |
| Otsuka America Pharmaceutical, Inc. | 4 | $88 |
| Exact Sciences | 5 | $85 |
| Phathom Pharmaceuticals, Inc. | 3 | $77 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $63 |
| GSK | 4 | $58 |
| E.r. Squibb & Sons, L.L.C. | 2 | $49 |
| Merck | 3 | $44 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $32 |
| Irhythm Technologies, Inc. | 1 | $22 |
| Amarin Pharma, Inc. | 1 | $16 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
How this compares
$3,148 in reported general payments places this provider in the 85th percentile of 3,248 family providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 79 | $119,051 |
| EliquisApixaban | 125 | $113,383 |
| JardianceEmpagliflozin | 73 | $87,595 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 70 | $78,407 |
| MounjaroTirzepatide | 62 | $68,734 |
| JanuviaSitagliptin Phosphate | 40 | $48,420 |
| LinzessLinaclotide | 49 | $44,733 |
| TrulicityDulaglutide | 28 | $32,698 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 37 | $23,087 |
| FarxigaDapagliflozin Propanediol | 29 | $21,771 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 74 | $17,601 |
| VraylarCariprazine Hcl | 12 | $16,321 |
| XareltoRivaroxaban | 24 | $13,776 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 11 | $13,582 |
| Tresiba Flextouch U-100Insulin Degludec | 20 | $12,002 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $331 | $119,05179 claims |
| PfizerEliquis | $111 | $113,383125 claims |
| Lilly USA, LLCMounjaro, Trulicity | $446 | $101,43190 claims |
| Boehringer IngelheimJardiance, Synjardy Xr | $97 | $101,17784 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $58 | $86,74783 claims |
| MerckJanuvia, Janumet Xr, Lagevrio (Eua) | $44 | $78,09291 claims |
| AbbVieLinzess, Vraylar | $573 | $61,05461 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $229 | $36,92357 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $201 | $8,21111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,248 family providers in South Carolina.
Other family in Edgefield
- Alison FogartyGreenville$2M
- Sara ChristieGreenville$229K
- Kara Cooper GilmerAnderson$127K
- Jessica BellEasley$96K
- Carrie HendersonGreenville$91K
- Sarah ValerioGreer$76K
- Mary WilliamsColumbia$67K
- Michelle StrongGreenville$55K
- Karen McKerihanSummerville$54K
- Doris ReidSimpsonville$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.